Quantumzyme Corp.
OTC: QTZM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Naveen Krishnarao Kulkarni
- Employees
- 1
- Headquarters
- San Diego, United States
- IPO year
- 2024
- Market cap
- $31.2M
- Website
- https://www.quantumzymecorp.com
Loading QTZM…
Loading profile data…Frequently asked questions about QTZM
What does Quantumzyme Corp. (QTZM) do?
Quantumzyme Corp. is a biotransformation firm specializing in the creation of engineered enzymes, primarily utilized for the production of active pharmaceutical ingredients (APIs). Established in 2015, the company was formerly known as Reliant Services, Inc. until it rebranded as Quantumzyme Corp. in March 2023. Its operations are headquartered...
Where does QTZM trade?
Quantumzyme Corp. (QTZM) trades on the Other OTC.
What sector is QTZM in?
Quantumzyme Corp. (QTZM) operates in the Basic Materials sector, specifically in the Chemicals - Specialty industry.
Who is the CEO of Quantumzyme Corp.?
Naveen Krishnarao Kulkarni is the chief executive officer of Quantumzyme Corp. (QTZM).
Where is Quantumzyme Corp. headquartered?
Quantumzyme Corp. is headquartered in United States.
Does QTZM pay a dividend?
Quantumzyme Corp. (QTZM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did QTZM go public?
Quantumzyme Corp. (QTZM) completed its initial public offering in 2024.